A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Clinical trial NCT06150664 · RECRUITING

Trial details

NCT number: NCT06150664
Sponsor: Compass Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Triple Negative Breast Cancer Hodgkin Lymphoma Head and Neck Squamous Cell Carcinoma Malignant Melanoma

Start date: 2024-03-19
Primary completion: 2026-12-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.